Table 4.
Clinical validity of the IDEEL (Pearson correlation coefficients)
| Clinical tests | IDEEL Modules | |||||
|---|---|---|---|---|---|---|
| Dry Eye Symptom-Bother* | Impact Daily Life | Dry Eye Treatment Satisfaction | ||||
| Impact on Daily Activities* | Emotional Impact due to Dry Eye* | Impact on Work due to Dry Eye* | Satisfaction with Treatment-Effectiveness* | Treatment-related Bother/ Inconvenience* |
||
| Snellen visual acuity | 0.22** | -0.25** | -0.24** | -0.09 | -0.07 | -0.25** |
| Bulbar redness | 0.18** | -0.15** | -0.22** | -0.18 | 0.01 | -0.25** |
| Schirmer 1 tear test (mm) | -0.30** | 0.14** | 0.24** | 0.11 | 0.09 | 0.37** |
| Fluorescein break up time (sec) | -0.22** | 0.17** | 0.20** | 0.22** | 0.01 | 0.28** |
| Overall corneal fluorescein staining rating | 0.31** | -0.21** | -0.25** | -0.30** | 0.06 | -0.32** |
| Conjunctival lissamine green staining rating | 0.30** | -0.17** | -0.25** | -0.29** | 0.03 | -0.31** |
* Number of patients ranging from 206 to 209 for Dry Eye Symptom-Bother, Impact on Daily Activities and Emotional Impact due to Dry Eye; ranging from 129 to 131 for Impact on Work due to Dry Eye; ranging from 135 to 137 for Satisfaction with Treatment Effectiveness; ranging form 151 to 154 for Treatment -Related Bother/Inconvenience
** p < 0.05